Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

Ishii T; Matsumoto N; Sano F; Takahashi H; Sato A; Adachi K

首页> 外文期刊>Case Reports in Gastroenterology >Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

【24h】

Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

机译：Peginterferon加利巴韦林治疗慢性丙型肝炎病毒基因型1b患者6周后延迟清除病毒

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Following interferon-based therapy for chronic hepatitis C, the negativity of hepatitis C virus RNA is essential to achieve viral clearance at the end of treatment. We report a case of clearance of chronic hepatitis C virus infection following early disco

机译：在对慢性丙型肝炎进行基于干扰素的治疗后，丙型肝炎病毒RNA的阴性必须在治疗结束时实现病毒清除。我们报告了早期迪斯科舞后清除慢性C型肝炎病毒感染的情况

著录项

来源
《Case Reports in Gastroenterology》 |2016年第2期|共页
作者
Ishii T; Matsumoto N; Sano F; Takahashi H; Sato A; Adachi K;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin. [J] . Akuta N, Suzuki F, Hirakawa Journal of Medical Virology . 2010,第4期

机译：基因型1b的丙型肝炎病毒核心区域中的氨基酸取代会影响telaprevir，peginterferon和利巴韦林治疗期间的早期病毒动力学。
2. Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load. [J] . Mizuta T, Kawaguchi Y, Eguchi Digestive Diseases and Sciences . 2010,第1期

机译：全身胰岛素敏感性指数是基因型1b和高病毒载量的慢性丙型肝炎患者对聚乙二醇干扰素联合病毒唑治疗的病毒学应答的高度特异性的预测指标。
3. Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load [J] . Toshihiko Mizuta, Yasunori Kawaguchi, Yuichiro Eguchi, Digestive Diseases and Sciences . 2010,第1期

机译：全身胰岛素敏感性指数是基因型1b和高病毒载量的慢性丙型肝炎患者对聚乙二醇干扰素联合利巴韦林治疗的病毒学应答的高度特异性的预测指标
4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015

机译：HLA-C基因在丙型肝炎病毒中感染埃及患者，估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
5. Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis c genotype 1 infection [D] . Wu, Liviawati Sutjandra. 2015

机译：利巴韦林全身和细胞内暴露及其在慢性丙型肝炎基因型1感染中对病毒反应和贫血的作用
6. Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b [O] . Akira Sato, Toshiya Ishii, Kayo Adachi, 2016

机译：Peginterferon加利巴韦林治疗慢性丙型肝炎病毒基因型1b患者6周后延迟清除病毒
7. Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b [O] . Akira Sato, Toshiya Ishii, Kayo Adachi, 2016

机译：慢性丙型肝炎病毒基因型1b患者用聚乙二醇干扰素加利巴韦林治疗6周后病毒清除延迟

Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b

摘要

著录项

相似文献

相关主题

期刊订阅